{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:31:38Z","timestamp":1788345098851,"version":"build-2803163510"},"reference-count":197,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Testosterone (T) deficiency (TD) may significantly affect sexual function and multiple organ systems.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To provide recommendations and Standard Operating Procedures (SOPs) based on best evidence for diagnosis and treatment of TD in men<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Medical literature was reviewed by the Endocrine subcommittee of the ISSM Standards Committee, followed by extensive internal discussion over two years, then public presentation and discussion with other experts<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Recommendations and SOPs based on grading of evidence-based medical literature and interactive discussion<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>TD is the association of a low serum T with consistent symptoms or signs. T level tends to decline with age. T modulates sexual motivation and erection. It also plays a broader role in men's health. Recent studies have established associations between low T, male sexual dysfunctions and metabolic risk factors. Though association does not mean causation, low T is associated with reduced longevity, risk of fatal cardiovascular events, obesity, sarcopenia, mobility limitations, osteoporosis, frailty, cognitive impairment, depression, Sleep Apnea Syndrome, and other chronic diseases. The paper proposes a standardized process for diagnosis and treatment of TD, and updates the knowledge on T therapy (Tth) and prostate and cardiovascular safety. There is no compelling evidence that Tth causes prostate cancer or its progression in men without severe TD. Polycythemia is presently the only cardiovascular-related adverse-event significantly associated with Tth. But follow-up of controlled T trials is limited to 3 years<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Men with sexual dysfunctions, and\/or with visceral obesity and metabolic diseases should be screened for TD and treated. Young men with TD should also be treated. Benefits and risks of Tth should be carefully assessed in older men. Prospective, long-term, placebo-controlled, interventional studies are required before screening for TD in more conditions, including cardiovascular diseases, and considering correction of TD as preventive medicine.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2012.02783.x","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T14:41:16Z","timestamp":1347460876000},"page":"245-284","source":"Crossref","is-referenced-by-count":222,"title":["Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment"],"prefix":"10.1093","volume":"10","author":[{"given":"Jacques","family":"Buvat","sequence":"first","affiliation":[{"name":"Centre d'Etudes et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique (CETPARP) , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[{"name":"Sexual Medicine & Andrology \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 , Florence , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Guay","sequence":"additional","affiliation":[{"name":"Center For Sexual Function\/Endocrinology \u00a0 , Peabody, MA , USA"},{"name":"Lahey Clinic Northshore \u00a0 , Peabody, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Otavio","family":"Torres","sequence":"additional","affiliation":[{"name":"Clinica de Urologia e Andrologia , Belo-Horizonte , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,1]]},"reference":[{"key":"2024032602351176700_bb0010","first-page":"347","article-title":"Endocrine aspects of men sexual dysfunction","author":"Morales","year":"2004","journal-title":"Sexual medicine, sexual dysfunctions in men and women, 2nd international consultation on sexual dysfunctions, Paris"},{"key":"2024032602351176700_bb0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/9780470755235.ch18","article-title":"Metabolism, aging, and men's health","author":"Buvat","year":"2006","journal-title":"Standard practice in sexual medicine"},{"key":"2024032602351176700_bb0020","first-page":"684","volume-title":"Report of committee 14, Endocrine Aspects of Male Sexual Dysfunctions in Sexual Medicine, Sexual Dysfunction in men and women","author":"Buvat","year":"2010"},{"key":"2024032602351176700_bb0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-08-0601","article-title":"Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations","volume":"159","author":"Wang","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0030","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with Androgen deficiency syndromes: An endocrine society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1743-6109.2010.02200.x","article-title":"Update on testosterone therapy in men","volume":"8","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2265.2008.03365.x","article-title":"Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men","volume":"70","author":"Vanbillemont","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2217\/pgs.09.58","article-title":"Pharmacogenetics of testosterone therapy replacement","volume":"10","author":"Zitzmann","year":"2009","journal-title":"Pharmacogenomics"},{"key":"2024032602351176700_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/EJE-09-0123","article-title":"Small effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men","volume":"161","author":"Bogaert","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0055","article-title":"The androgen receptor CAG repeat polymorphism as a risk factor of low serum testosterone and its cardiometabolic effects in men","author":"Haring","year":"2011","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2008-0848","article-title":"Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats","volume":"94","author":"Uhtaniemi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.beem.2010.11.004","article-title":"Endocrinology of the aging male","volume":"25","author":"Araujo","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hpogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"2024032602351176700_bb0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","article-title":"Prevalence of hypogonadism in males aged at least 45 years: The HIM study","volume":"60","author":"Mulligan","year":"2006","journal-title":"Int J Clin Pract"},{"key":"2024032602351176700_bb0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/dc08-2216","article-title":"Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: Multi-ethnic study of atherosclerosis","volume":"32","author":"Colangelo","year":"2009","journal-title":"Diabetes Care"},{"key":"2024032602351176700_bb0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/EJE-09-0348","article-title":"Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: The Health In Men Study","volume":"161","author":"Yeap","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ucl.2011.02.004","article-title":"Testosterone deficiency and risk factors in the metabolic syndrome: Implications for erectile dysfunction","volume":"38","author":"Guay","year":"2011","journal-title":"Urol Clin North Am"},{"key":"2024032602351176700_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: A meta-analysis study","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1743-6109.2010.01991.x","article-title":"Testosterone and metabolic syndrome: A meta-analysis study","volume":"8","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/HJR.0b013e32833c1a8d","article-title":"Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia","volume":"18","author":"Haring","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2024032602351176700_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/13685538.2010.529194","article-title":"Inverse association between total testosterone concentrations, incident hypertension and blood pressure","volume":"14","author":"Torkler","year":"2011","journal-title":"Aging Male"},{"key":"2024032602351176700_bb0115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/hrt.2010.210757","article-title":"Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis","volume":"97","author":"Ruige","year":"2011","journal-title":"Heart"},{"key":"2024032602351176700_bb0120","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0125","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1111\/j.1743-6109.2010.01931.x","article-title":"Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: Results from a 24-month, randomized, double-blind, placebo-controlled study","volume":"7","author":"Aversa","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CMAR.S16893","article-title":"Cardiovascular risk during hormonal treatment in patients with prostate cancer","volume":"3","author":"Van Poppel","year":"2011","journal-title":"Cancer Manag Res"},{"key":"2024032602351176700_bb0135","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1200\/JCO.2011.35.1494","article-title":"Androgen deprivation therapy and cardiovascular risk","volume":"29","author":"Punnen","year":"2011","journal-title":"J Clin Oncol"},{"key":"2024032602351176700_bb0140","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Endogenous testosterone and mortality in men: A systematic review and meta-analyses","volume":"96","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0145","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/eurheartj\/ehq009","article-title":"Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20\u201379","volume":"31","author":"Haring","year":"2010","journal-title":"Eur Heart J"},{"key":"2024032602351176700_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000324562","article-title":"Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy","volume":"33","author":"Haring","year":"2011","journal-title":"Am J Nephrol"},{"key":"2024032602351176700_bb0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2008060664","article-title":"Low serum testosterone increases mortality risk among male dialysis patients","volume":"20","author":"Carrero","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2024032602351176700_bb0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/jc.2007-1792","article-title":"Low serum testosterone and mortality in older men","volume":"93","author":"Laughlin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0165","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2605.2009.01029.x","article-title":"Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men","volume":"33","author":"Haring","year":"2010","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0170","first-page":"375","article-title":"Testosterone and cardiovascular diseases","author":"von Eckardstein","year":"2004","journal-title":"Testosterone: Action, deficiency, substitution"},{"key":"2024032602351176700_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/VHRM.S1255","article-title":"Androgen therapy and atherosclerotic cardiovascular disease","volume":"4","author":"Mc Grath","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"2024032602351176700_bb0180","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/j.1743-6109.2011.02292.x","article-title":"Body mass index regulates hypogonadism-associated CV risk: Results from a cohort of subjects with erectile dysfunction","volume":"8","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0185","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/jc.2006-0173","article-title":"Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men","volume":"91","author":"Fink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0190","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1210\/jc.2009-2635","article-title":"Sex steroid hormones in older men: Longitudinal associations with 4.5-year change in hip bone mineral density-the osteoporotic fractures in men study","volume":"95","author":"Cauley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0195","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1210\/jc.2011-0143","article-title":"Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: The concord health and ageing in men project","volume":"96","author":"Travison","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0200","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1532-5415.2011.03398.x","article-title":"Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: Results from the European male aging study","volume":"59","author":"Tajar","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"2024032602351176700_bb0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2007.03.014","article-title":"Male hypogonadism in systemic disease","volume":"36","author":"Kalyani","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2024032602351176700_bb0210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2265.2010.03925.x","article-title":"The NERI Hypogonadism Screener: Psychometric validation in male patients and controls","volume":"74","author":"Rosen","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0215","article-title":"Standard operating procedure for puberta tarda\/delayed puberty","author":"Maggi","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0220","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1743-6109.2008.00803.x","article-title":"Different testosterone levels are associated with ejaculation dysfunction","volume":"5","author":"Corona","year":"2008","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0225","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2605.2008.00951.x","article-title":"Hypogonadism, ED, metabolic syndrome and obesity: A pathological link supporting cardiovascular diseases","volume":"32","author":"Corona","year":"2009","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jomh.2009.05.002","article-title":"Recognising late-onset hypogonadism: A difficult task for sexual health care","volume":"6","author":"Corona","year":"2009","journal-title":"J Mens Health"},{"issue":"1","key":"2024032602351176700_bb0235","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1743-6109.2009.01549.x","article-title":"The relationship of testosterone to prostatic-specific androgen in men with sexual dysfunction","volume":"7","author":"Corona","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0240","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00345-006-0131-x","article-title":"Significance of hypogonadism in erectile dysfunction","volume":"24","author":"Buvat","year":"2006","journal-title":"World J Urol"},{"key":"2024032602351176700_bb0245","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2006-0401","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men","volume":"91","author":"Zitzmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.maturitas.2005.07.004","article-title":"Comparison of screening questionnaires for the diagnosis of hypogonadism","volume":"53","author":"Morley","year":"2006","journal-title":"Maturitas"},{"key":"2024032602351176700_bb0255","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2265.2010.03954.x","article-title":"Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires","volume":"74","author":"Emmelot-Vonk","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0260","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1743-6109.2006.00262.x","article-title":"ANDROTEST(c): A structured interview for the screening of hypogonadism in patients with sexual dysfunction","volume":"3","author":"Corona","year":"2006","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ijir.2009.46","article-title":"Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses","volume":"22","author":"Guay","year":"2010","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0270","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0275","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1210\/jc.2003-031287","article-title":"Measurement of total serum testosterone in adult men: Comparison of current laboratory methods vs. liquid chromatography-tandem mass spectrometry","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0280","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1373\/clinchem.2005.063354","article-title":"Calculation of bioavailable and free testosterone in men: A comparison of 5 published algorithms","volume":"52","author":"De Ronde","year":"2006","journal-title":"Clin Chem"},{"key":"2024032602351176700_bb0285","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1743-6109.2009.01473.x","article-title":"Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population","volume":"7","author":"Moreno","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0290","article-title":"Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, DHEA)","author":"Maggi","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-5347(01)66441-3","article-title":"Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism","volume":"155","author":"Citron","year":"1996","journal-title":"J Urol"},{"key":"2024032602351176700_bb0300","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2265.2007.02976.x","article-title":"Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men","volume":"67","author":"Brambilla","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.ijir.3901580","article-title":"Does early morning vs. late morning draw time influence apparent testosterone concentration in men aged &gt; or =45 years? Data from the Hypogonadism In Males study","volume":"20","author":"Guay","year":"2008","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0310","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2605.1999.00196.x","article-title":"Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone","volume":"22","author":"Jannini","year":"1999","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0315","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2265.2004.02108.x","article-title":"Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels","volume":"61","author":"Carosa","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0320","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2005-0247","article-title":"Dose-dependant effects of testosterone on sexual function, mood, and visuospatial cognition on older men","volume":"90","author":"Gray","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2265.2004.02174.x","article-title":"Normal, bound and nonbound testosterone levels in normally ageing men: Results from the Massachusetts Male Ageing Study","volume":"62","author":"Mohr","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0330","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/jc.2010-0266","article-title":"Why is androgen replacement in males controversial?","volume":"96","author":"Cunningham","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0335","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Adverse effects of testosterone therapy in adult men: A systematic review and meta-analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0340","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"2024032602351176700_bb0345","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jc.2010-2538","article-title":"Testosterone treatment of older men: Why are controversies created?","volume":"96","author":"Swerdloff","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0350","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jc.2004-0970","article-title":"The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: A prospective cohort study","volume":"90","author":"Laaksonen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0355","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/oby.2003.98","article-title":"Sex hormones and sexual function in obese men losing weight","volume":"11","author":"Kaukua","year":"2003","journal-title":"Obes Res"},{"key":"2024032602351176700_bb0360","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1462-8902.2004.00335.x","article-title":"Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome","volume":"6","author":"Niskanen","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"2024032602351176700_bb0365","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ijo.2010.76","article-title":"Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men","volume":"34","author":"Khoo","year":"2010","journal-title":"Int J Obes"},{"key":"2024032602351176700_bb0370","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00198-005-1906-4","article-title":"Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes?","volume":"16","author":"Daly","year":"2005","journal-title":"Osteoporos Int"},{"key":"2024032602351176700_bb0375","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0026-0495(99)90125-7","article-title":"Plasma adrenal, gonadal, and conjugated steroids following long-term exercise-induced negative energy balance in identical twins","volume":"48","author":"Pritchard","year":"1999","journal-title":"Metabolism"},{"key":"2024032602351176700_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000008556","article-title":"Sex hormone changes in morbidly obese patients after vertical banded gastroplasty","volume":"30","author":"Bastounis","year":"1998","journal-title":"Eur Surg Res"},{"key":"2024032602351176700_bb0385","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.genm.2011.05.007","article-title":"Sex hormones and bariatric surgery in men","volume":"8","author":"Rao","year":"2011","journal-title":"Gend Med"},{"key":"2024032602351176700_bb0390","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/jc.2008-1598","article-title":"Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men","volume":"94","author":"Hammoud","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0395","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2605.2009.01017.x","article-title":"Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: A prospective randomized controlled trial","volume":"33","author":"Reis","year":"2010","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0400","first-page":"874","article-title":"Hormonal responses after a strength endurance resistance exercise protocol in young and elderly males","volume":"20","author":"Smilios","year":"2007","journal-title":"Int J Sports Med"},{"key":"2024032602351176700_bb0405","first-page":"874","article-title":"Effects of age on testosterone responses to resistance exercise and musculoskeletal variables in men","volume":"20","author":"Baker","year":"2006","journal-title":"J Stength Cond Res"},{"key":"2024032602351176700_bb0410","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1249\/mss.0b013e31815bbba9","article-title":"Effect of exercise on serum sex hormones in men: A 12-month randomized clinical trial","volume":"40","author":"Hawkins","year":"2008","journal-title":"Med Sci Sports Exerc"},{"key":"2024032602351176700_bb0415","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21101\/cejph.a3589","article-title":"Effect of endurance exercise on resting testosterone levels in sedentary subjects","volume":"18","author":"Hiruntrakul","year":"2010","journal-title":"Cent Eur J Public Health"},{"key":"2024032602351176700_bb0420","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.eururo.2005.02.015","article-title":"Correlations between hormones, physical, and affective parameters in aging urologic outpatients","volume":"47","author":"Beutel","year":"2005","journal-title":"Eur Urol"},{"key":"2024032602351176700_bb0425","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ijir.3901158","article-title":"Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction","volume":"16","author":"Corona","year":"2004","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0430","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1210\/jc.2005-2508","article-title":"The relationship between libido and testosterone in aging men: Results from the Massachussetts Male Aging Study","volume":"91","author":"Travison","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2265.2005.02350.x","article-title":"Effects of testosterone on sexual function in men: Results of a meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0440","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0025-6196(11)60963-4","article-title":"Testosterone use in men with sexual dysfunction: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Bolona","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2024032602351176700_bb0445","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ijir.2008.22","article-title":"Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency","volume":"20","author":"Allan","year":"2008","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0450","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"key":"2024032602351176700_bb0455","doi-asserted-by":"crossref","first-page":"E1577","DOI":"10.1210\/jc.2010-2216","article-title":"The relationships between sex hormones and sexual function in middle-aged and older european men","volume":"96","author":"O'Connor","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0460","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.ijir.3900852","article-title":"Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction?","volume":"14","author":"Rhoden","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0465","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.juro.2006.08.020","article-title":"Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study","volume":"176","author":"Kupelian","year":"2006","journal-title":"J Urol"},{"key":"2024032602351176700_bb0470","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1464-410X.2010.09766.x","article-title":"Low serum testosterone levels are poor predictors of sexual dysfunction","volume":"108","author":"Marberger","year":"2011","journal-title":"BJU Int"},{"key":"2024032602351176700_bb0475","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2605.2009.00952.x","article-title":"The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction","volume":"32","author":"Corona","year":"2009","journal-title":"Int J Androl"},{"key":"2024032602351176700_bb0480","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1743-6109.2006.00245.x","article-title":"Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence","volume":"3","author":"Traish","year":"2006","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0485","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF03349232","article-title":"Which patients with sexual dysfunction are suitable for testosterone replacement therapy?","volume":"30","author":"Morelli","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"2024032602351176700_bb0490","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-151-9-200911030-00150","article-title":"Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis","volume":"151","author":"Tsertsvadze","year":"2009","journal-title":"Ann Intern Med"},{"key":"2024032602351176700_bb0495","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(01)64123-5","article-title":"Endocrine screening in 1022 men with erectile dysfunction: Clinical significance and cost-effective strategy","volume":"158","author":"Buvat","year":"1997","journal-title":"J Urol"},{"key":"2024032602351176700_bb0500","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00345-006-0120-0","article-title":"Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido)","volume":"24","author":"Yassin","year":"2006","journal-title":"World J Urol"},{"key":"2024032602351176700_bb0505","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.ijir.3900832","article-title":"Sexual inactivity results in reversible reduction of LH bioavailability","volume":"14","author":"Carosa","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0510","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-11-0221","article-title":"Onset of effects of testosterone treatment and time span until maximum effects are achieved","volume":"165","author":"Saad","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0515","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/j.1743-6109.2009.01467.x","article-title":"Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome","volume":"6","author":"Filippi","year":"2009","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0520","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11930-008-0024-7","article-title":"Combination therapy with phosphodiesterase type V inhibitors and testosterone","volume":"5","author":"Buvat","year":"2008","journal-title":"Curr Sex Health Rep"},{"key":"2024032602351176700_bb0525","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-2265.2003.01764.x","article-title":"Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction","volume":"58","author":"Aversa","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0530","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.ju.0000132389.97804.d7","article-title":"Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone","volume":"172","author":"Shabsigh","year":"2004","journal-title":"J Urol"},{"key":"2024032602351176700_bb0535","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1743-6109.2010.01956.x","article-title":"Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)","volume":"8","author":"Buvat","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0540","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0545","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1532-5415.2006.00938.x","article-title":"Androgen treatment and muscle strength in elderly men: A meta-analysis","volume":"54","author":"Ottenbacher","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"2024032602351176700_bb0550","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1152\/ajpendo.00362.2001","article-title":"Testosterone administration to older men improves muscle function: Molecular and physiological mechanisms","volume":"282","author":"Ferrando","year":"2002","journal-title":"Am J Physicol Endocrinol Metab"},{"key":"2024032602351176700_bb0555","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"2024032602351176700_bb0560","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9343(01)00833-6","article-title":"Intramuscular testosterone esters and plasma lipids in hypogonadal men: A meta-analysis","volume":"11","author":"Whitsel","year":"2001","journal-title":"Am J Med"},{"key":"2024032602351176700_bb0565","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: The double-blinded placebo-controlled Moscow study","volume":"73","author":"Kalinchenko","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0570","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1532-5415.2010.02865.x","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty","volume":"58","author":"Kenny","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"2024032602351176700_bb0575","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1210\/jc.2006-0036","article-title":"Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"91","author":"Tracz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0580","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0585","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/jc.2002-021827","article-title":"Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systematic glucocorticoid treatment","volume":"88","author":"Crawford","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0590","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.maturitas.2011.05.012","article-title":"Testosterone levels and cognition in elderly men: A review","volume":"69","author":"Holland","year":"2011","journal-title":"Maturitas"},{"key":"2024032602351176700_bb0595","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1530\/EJE-09-0970","article-title":"Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: Results from the European Male Ageing Study","volume":"162","author":"Lee","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0600","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.2009.03692.x","article-title":"Association between sex steroids and cognition in elderly men","volume":"72","author":"LeBlanc","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0605","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1210\/jc.2009-1346","article-title":"Cognition is not modified by large but temporary changes in sex hormones in men","volume":"95","author":"Young","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0610","first-page":"3578","article-title":"Testosterone replacement therapy, improves mood in hypogonadal men: A clinical research center study","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0615","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.pra.0000358315.88931.fc","article-title":"Testosterone and depression: Systematic review and meta-analysis","volume":"15","author":"Zarrouf","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"2024032602351176700_bb0620","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/13685538.2010.522276","article-title":"Testosterone levels and psychological health status in men from a general population: The Troms\u00f8 study","volume":"14","author":"Berglund","year":"2011","journal-title":"Aging Male"},{"key":"2024032602351176700_bb0625","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.61.2.162","article-title":"Increased incidence of diagnosed depressive illness in hypogonadal older men","volume":"61","author":"Shores","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"2024032602351176700_bb0630","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/JGP.0b013e3181e70c22","article-title":"Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples","volume":"19","author":"Schneider","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"2024032602351176700_bb0635","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1111\/j.1743-6109.2011.02443.x","article-title":"Sex hormone levels, genetic androgen receptor polymorphism, and anxiety in \u226550-year-old males","volume":"8","author":"Schneider","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0640","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1530\/EJE-10-0090","article-title":"Testosterone, androgen receptor gene CAG repeat length, mood and behaviour in adolescent males","volume":"163","author":"Vermeersch","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0645","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1176\/appi.ajp.160.1.105","article-title":"Testosterone gel supplementation for men with refractory depression: A randomized, placebo-controlled trial","volume":"160","author":"Pope","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2024032602351176700_bb0650","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/JCP.0b013e3181d207ca","article-title":"Parallel -group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment","volume":"30","author":"Pope","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"2024032602351176700_bb0655","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/0092623X.2011.582425","article-title":"Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: A randomized, placebo-controlled clinical trial","volume":"37","author":"Amiaz","year":"2011","journal-title":"J Sex Marital Ther"},{"key":"2024032602351176700_bb0660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/13685538.2010.518178","article-title":"Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: A randomised controlled study","volume":"14","author":"Shigehara","year":"2011","journal-title":"Aging Male"},{"key":"2024032602351176700_bb0665","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2265.2011.04152.x","article-title":"Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men","volume":"75","author":"Wang","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0670","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jsbmb.2007.10.010","article-title":"Efficacity and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal men","volume":"109","author":"Raynaud","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024032602351176700_bb0675","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/humrep\/den372","article-title":"Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies","volume":"24","author":"de Ronde","year":"2009","journal-title":"Hum Reprod"},{"key":"2024032602351176700_bb0680","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1745-7262.2007.00275.x","article-title":"More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate","volume":"9","author":"Saad","year":"2007","journal-title":"Asian J Androl"},{"key":"2024032602351176700_bb0685","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/jcem.87.4.8138","article-title":"The effects of transdermal dihydrotestosterone in the aging male: A prospective, randomized, double blind study","volume":"87","author":"Kunelius","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0690","article-title":"Hormonal causes of Male Sexual Dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, Dehydroepiandrosterone","author":"Maggi","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0695","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1210\/jcem.87.7.8630","article-title":"A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency","volume":"87","author":"Liu","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0700","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/13685530500282794","article-title":"Treatment with human chorionic gonadotropin for PADAM: A preliminary report","volume":"8","author":"Tsujimura","year":"2005","journal-title":"Aging Male"},{"key":"2024032602351176700_bb0705","first-page":"3546","article-title":"Effects of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo-controlled trial with clomiphene citrate","volume":"80","author":"Guay","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0710","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.ijir.3900981","article-title":"Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: Who does and does not benefit?","volume":"15","author":"Guay","year":"2009","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0715","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1743-6109.2009.01454.x","article-title":"Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: Efficacy and treatment cost","volume":"7","author":"Taylor","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0720","article-title":"Outcomes of clomiphene citrate treatment in young hypogonadal men","author":"Katz","year":"2011","journal-title":"BJU Int"},{"key":"2024032602351176700_bb0725","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-09-0084","article-title":"Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment","volume":"161","author":"Ribeiro","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0730","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000180947","article-title":"Antiestrogens as treatment of female and male infertilities","volume":"28","author":"Buvat","year":"1987","journal-title":"Horm Res"},{"key":"2024032602351176700_bb0735","first-page":"109","article-title":"Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men","volume":"12","author":"Hill","year":"2009","journal-title":"Drugs"},{"key":"2024032602351176700_bb0740","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/EJE-07-0663","article-title":"Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism","volume":"158","author":"Loves","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0745","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ncpendmet0844","article-title":"Treatment of male infertility secondary to morbid obesity","volume":"4","author":"Roth","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2024032602351176700_bb0750","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1210\/jc.2009-0739","article-title":"Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels","volume":"94","author":"Burnett-Bowie","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0755","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.steroids.2008.09.012","article-title":"Distribution, metabolism and excretion of a synthetic androgen 7alpha-methyl-19-nortestosterone, a potential male-contraceptive","volume":"74","author":"Prasad","year":"2009","journal-title":"Steroids"},{"key":"2024032602351176700_bb0760","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jsbmb.2010.06.009","article-title":"The potent synthetic androgens, dimethandrolone (7\u03b1,11\u03b2-dimethyl-19-nortestosterone) and 11\u03b2-methyl-19-nortestosterone, do not require 5\u03b1-reduction to exert their maximal androgenic effects","volume":"122","author":"Attardi","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024032602351176700_bb0765","first-page":"3556","article-title":"7-Methyl-19-nortestosterone (MENT) maintains sexual behavior and mood in hypogonadal men","volume":"84","author":"Anderson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0770","first-page":"4212","article-title":"Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: A potential alternative to testosterone for androgen replacement and male contraception","volume":"83","author":"Cummings","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0775","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jc.2002-021960","article-title":"Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men","volume":"88","author":"Anderson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0780","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2011.06.002","article-title":"Recent developments in antiandrogens and selective androgen receptor modulators","volume":"352","author":"Haendler","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2024032602351176700_bb0785","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: Results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024032602351176700_bb0790","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF03347072","article-title":"Androgen regulation of prostate cancer: Where are we now?","volume":"34","author":"Corona","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"2024032602351176700_bb0795","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1743-6109.2011.02233.x","article-title":"Is testosterone a friend or a foe for the prostate","volume":"8","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0800","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"2024032602351176700_bb0805","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"2024032602351176700_bb0810","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.urology.2007.05.025","article-title":"Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men","volume":"70","author":"Liu","year":"2007","journal-title":"Urology"},{"key":"2024032602351176700_bb0815","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2265.2001.01240.x","article-title":"Effects of androgen deficiency ans replacement on prostate zonal volumes","volume":"54","author":"Jin","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351176700_bb0820","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2005-1947","article-title":"Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia","volume":"91","author":"Marberger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0825","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endrogenous hormones prostates cancer collaborative group, Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2024032602351176700_bb0830","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","article-title":"Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependant growth","volume":"55","author":"Morgentaler","year":"2009","journal-title":"Eur Urol"},{"key":"2024032602351176700_bb0835","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trial","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024032602351176700_bb0840","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ijir.2008.31","article-title":"Testosterone therapy in hypogonadal men and potential prostate cancer risk: A systematic review","volume":"21","author":"Shabsigh","year":"2009","journal-title":"Int J Impot Res"},{"key":"2024032602351176700_bb0845","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1097\/01.ju.0000091104.71869.8e","article-title":"Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: Results of 1 year of treatment in men with prostatic intraepithelial neoplasia","volume":"170","author":"Rhoden","year":"2003","journal-title":"J Urol"},{"key":"2024032602351176700_bb0850","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.juro.2010.11.084","article-title":"Testosterone therapy in men with untreated prostate cancer","volume":"185","author":"Morgentaler","year":"2011","journal-title":"J Urol"},{"key":"2024032602351176700_bb0855","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.296.19.2351","article-title":"Efforts of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: A randomized controlled trial","volume":"296","author":"Marks","year":"2006","journal-title":"JAMA"},{"key":"2024032602351176700_bb0860","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.juro.2008.01.142","article-title":"Change in prostate specific antigen following androgen stimulation is an independent predictor of prostate cancer diagnosis","volume":"179","author":"Svatek","year":"2008","journal-title":"J Urol"},{"key":"2024032602351176700_bb0865","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/pcan.2010.4","article-title":"Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer","volume":"13","author":"Gacci","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2024032602351176700_bb0870","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/pros.21174","article-title":"Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu","volume":"15","author":"Takizawa","year":"2010","journal-title":"Prostate"},{"key":"2024032602351176700_bb0875","volume-title":"Testosterone treatment after radical prostatectomy for pathologically organ-confined prostate cancer; results from a multi-institutional study","author":"Isbarn","year":"2010"},{"key":"2024032602351176700_bb0880","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1464-410X.2011.10193.x","article-title":"Effect of testosterone administration to men with prostate cancer is unpredictable: A word of caution and suggestions for a registry","volume":"107","author":"Morales","year":"2011","journal-title":"BJU Int"},{"key":"2024032602351176700_bb0885","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.pcan.4500833","article-title":"Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients","volume":"9","author":"Ferreira","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2024032602351176700_bb0890","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1464-410X.2009.08980.x","article-title":"Testosterone replacement in prostate cancer survivors with hypogonadal symptoms","volume":"105","author":"Leibowitz","year":"2010","journal-title":"BJU Int"},{"key":"2024032602351176700_bb0895","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4158\/EP.14.2.201","article-title":"Invasive breast cancer after initiation of testosterone replacement therapy in a man-a warning to endocrinologists","volume":"14","author":"Thomas","year":"2008","journal-title":"Endocr Pract"},{"key":"2024032602351176700_bb0900","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-005-9074-y","article-title":"Breast cancer and long-term hormonal treatment of male hypogonadism","volume":"96","author":"Medras","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"2024032602351176700_bb0905","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1634\/theoncologist.12-7-798","article-title":"Some aspects of the endocrine profile and management of hormone-dependent male breast cancer","volume":"12","author":"Dimitrov","year":"2007","journal-title":"Oncologist"},{"key":"2024032602351176700_bb0910","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2147\/VHRM.S4261","article-title":"Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the litterature","volume":"4","author":"Stergiopoulos","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"2024032602351176700_bb0915","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S0022-5347(17)38168-5","article-title":"Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence","volume":"146","author":"Krauss","year":"1991","journal-title":"J Urol"},{"key":"2024032602351176700_bb0920","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1743-6109.2007.00553.x","article-title":"Testosterone therapy and obstructive sleep apnea: Is there a real connection?","volume":"4","author":"Hanafy","year":"2007","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0925","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/00365517109090665","article-title":"The effect of testosterone in pharmacological doses on plasma volume and on some serum proteins in patients with sickle cell anemia and in sexually impotent men","volume":"28","author":"Lundh","year":"1971","journal-title":"Scand J Clin Lab Invest"},{"key":"2024032602351176700_bb0930","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJMoa066494","article-title":"Reversal of idiopathic hypogonadotropic hypogonadism","volume":"357","author":"Raivio","year":"2007","journal-title":"N Engl J Med"},{"key":"2024032602351176700_bb0935","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.2008-1648","article-title":"Induction of spermatogenesis and fertility during gonadotrophin treatment of gonadotrophin-deficient infertile men: Predictors of fertility outcome","volume":"94","author":"Liu","year":"2009","journal-title":"J Clin Endocrinol"},{"key":"2024032602351176700_bb0940","first-page":"3469","article-title":"Pharmacokinecs efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men","volume":"84","author":"Dobs","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0945","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.juro.2008.08.126","article-title":"Long acting testosterone undecanoate therapy in men with hypogonadism: Results of a pharmacokinetic clinical study","volume":"180","author":"Morgentaler","year":"2008","journal-title":"J Urol"},{"key":"2024032602351176700_bb0950","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0025-6196(11)60671-X","article-title":"Gynecomastia: Pathophysiology, evaluation, and management","volume":"84","author":"Johnson","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"2024032602351176700_bb0955","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-009-0379-0","article-title":"Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database","volume":"119","author":"Brinton","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2024032602351176700_bb0960","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1743-6109.2010.02082.x","article-title":"Precocious puberty secondary to topical testosterone transfer: A case report","volume":"8","author":"Cavender","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351176700_bb0965","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/oxfordjournals.humrep.a136051","article-title":"Tolerability of intramuscular injections of testosterone ester in oil vehicle","volume":"10","author":"Mackey","year":"1995","journal-title":"Hum Reprod"},{"key":"2024032602351176700_bb0970","first-page":"283","article-title":"Androgens and erythropoiesis","author":"Zitzmann","year":"2004","journal-title":"Testosterone: Action, deficiency, substitution"},{"key":"2024032602351176700_bb0975","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2007-1692","article-title":"Effects of graded doses of testosterone on erythropoiesis in healthy young and older men","volume":"93","author":"Coviello","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351176700_bb0980","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1530\/EJE-09-0717","article-title":"Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets","volume":"162","author":"Ip","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024032602351176700_bb0985","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/j.1939-4640.2003.tb02676.x","article-title":"Managing the risks of prostate disease during testosterone replacement therapy in older men: Recommendations for a standardized monitoring plan","volume":"24","author":"Bhasin","year":"2003","journal-title":"J Androl"},{"key":"2024032602351176700_bb0990","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N Engl J Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515301120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515301120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/1\/245\/48199024\/jsm_10_1_245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/1\/245\/48199024\/jsm_10_1_245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:55:37Z","timestamp":1711421737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/10\/1\/245\/6941144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":197,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,1]]},"published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02783.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,1]]},"published":{"date-parts":[[2013,1,1]]}}}